Sermorelin's FDA Journey: Approved, Discontinued, and Compounded Sermorelin acetate (Geref) was FDA-approved in 1997 for pediatric GHD 1 and in 1990 for diagnostic use.26 The manufacturer discontinued Geref in 2008 due to "manufacturing difficulties," not safety or efficacy concerns.12 In 2013, the FDA confirmed it wasn't withdrawn for safety/effectiveness, allowing for potential generic approvals.12 Currently, Sermorelin is primarily available as a compounded medication 3, which is permitted but not individually FDA-approved like mass-produced drugs.22 5.2
Glutathione and Inflammatory Disorders of the lungs
(8 Conversely, Ipamorelin has been associated with what appears to be a substantial increase in growth hormone levels, reaching levels that may be as high as 80mIU/l (approximately a 26.6ng/ml concentration)
doi: 10.3969/j.issn.1005-1678.2016.12.041 69 XiaojunHPingGXiaofeiX
Simple timing framework Baseline Discuss baseline labs before starting, especially with active injury, infection concern, liver disease, kidney disease, anemia, or copper metabolism concerns
That is why appearance changes matter even before you finish checking dates